Circulating exosome‐derived bona fide long non‐coding RNAs predicting the occurrence and metastasis of hepatocellular carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating exosome‐derived bona fide long non‐coding RNAs predicting the occurrence and metastasis of hepatocellular carcinoma
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 24, Issue 2, Pages 1311-1318
Publisher
Wiley
Online
2019-12-07
DOI
10.1111/jcmm.14783
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis
- (2019) Yufeng Wang et al. Molecular Cancer
- A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets
- (2019) Juan Bayo et al. JOURNAL OF HEPATOLOGY
- C/EBPα-dependent preneoplastic tumor foci are the origin of hepatocellular carcinoma and aggressive pediatric liver cancer
- (2018) Ashley Cast et al. HEPATOLOGY
- Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database
- (2018) Devalkumar J. Rajyaguru et al. JOURNAL OF CLINICAL ONCOLOGY
- Exosomes released by hepatocarcinoma cells endow adipocytes with tumor-promoting properties
- (2018) Shihua Wang et al. Journal of Hematology & Oncology
- Tumor-derived exosomes promote tumor self-seeding in hepatocellular carcinoma by transferring miRNA-25-5p to enhance cell motility
- (2018) Hao Liu et al. ONCOGENE
- Primary tumor-derived exosomes facilitate metastasis by regulating adhesion of circulating tumor cells via SMAD3 in liver cancer
- (2018) Qihan Fu et al. ONCOGENE
- 14-3-3ζ delivered by hepatocellular carcinoma-derived exosomes impaired anti-tumor function of tumor-infiltrating T lymphocytes
- (2018) Xiaochen Wang et al. Cell Death & Disease
- Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer
- (2018) Tian Fang et al. Nature Communications
- EGFR and c-MET cooperate to enhance resistance to PARP inhibitors in hepatocellular carcinoma
- (2018) Qiongzhu Dong et al. CANCER RESEARCH
- Super-enhancer-associated long non-coding RNA HCCL5 is activated by ZEB1 and promotes the malignancy of hepatocellular carcinoma
- (2018) Li Peng et al. CANCER RESEARCH
- Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma
- (2018) Yu Rim Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma
- (2017) Ander Arbelaiz et al. HEPATOLOGY
- Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy
- (2016) Hongzhao Qi et al. ACS Nano
- Positive feedback loop between cancer stem cells and angiogenesis in hepatocellular carcinoma
- (2016) Hong Yao et al. CANCER LETTERS
- Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
- (2015) Jessica Zucman-Rossi et al. GASTROENTEROLOGY
- Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma
- (2015) Yu-Suo Tong et al. Molecular Cancer
- Immunological landscape and immunotherapy of hepatocellular carcinoma
- (2015) Jesús Prieto et al. Nature Reviews Gastroenterology & Hepatology
- A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma
- (2014) J Tang et al. Cell Death & Disease
- Nuclear Pore Component Nup98 Is a Potential Tumor Suppressor and Regulates Posttranscriptional Expression of Select p53 Target Genes
- (2012) Stephan Singer et al. MOLECULAR CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now